<strong>Aim:</strong><span style="font-family:Verdana;"> To describe the epidemiological, therapeutic and prognostic aspects of eclampsia at the second reference hospital in the urban commu...<strong>Aim:</strong><span style="font-family:Verdana;"> To describe the epidemiological, therapeutic and prognostic aspects of eclampsia at the second reference hospital in the urban commune of Ségou in Mali.</span><span style="font-family:;" "=""> </span><b><span style="font-family:Verdana;">Patient and Methods:</span></b><span style="font-family:Verdana;"> This was a descriptive, cross-sectional, analytical, retrospective and prospective study based on a comprehensive de-engineering.</span><span style="font-family:Verdana;"> It covered a 3-year period from January 1, 2010 to December 31, 2012 and involved 176 cases.</span><span style="font-family:;" "=""> </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> The incidence of eclampsia during the study period was 2.9%. Classically, it occurred in 74.4% in young primigeste, in 73.9% in the</span><span style="font-family:;" "=""> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">3</span><sup><span style="font-family:Verdana;">rd</span></sup><span style="font-family:Verdana;"> trimester of pregnancy and 26.1% of cases during postpartum. We recorded maternal complications such as retro-placental hematoma, acute kidney failure and delivery hemorrhage. The case fatality rate was 2.3% or 4 cases of maternal death. At the fetal level, there was 29.5% prematurity, 31.8% neonatal suffering, 11.4% hypotrophy, 11.9% </span><i><span style="font-family:Verdana;">in</span></i></span><i><span style="font-family:;" "=""> </span></i><i><span style="font-family:Verdana;">utero</span></i><span style="font-family:Verdana;"> fetal death and 7.4% early neonatal death.</span><span style="font-family:;" "=""> </span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> The maternal-fetal prognosis remains reserved despite the progress made in the management of eclampsia in our services.</span>展开更多
文摘<strong>Aim:</strong><span style="font-family:Verdana;"> To describe the epidemiological, therapeutic and prognostic aspects of eclampsia at the second reference hospital in the urban commune of Ségou in Mali.</span><span style="font-family:;" "=""> </span><b><span style="font-family:Verdana;">Patient and Methods:</span></b><span style="font-family:Verdana;"> This was a descriptive, cross-sectional, analytical, retrospective and prospective study based on a comprehensive de-engineering.</span><span style="font-family:Verdana;"> It covered a 3-year period from January 1, 2010 to December 31, 2012 and involved 176 cases.</span><span style="font-family:;" "=""> </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> The incidence of eclampsia during the study period was 2.9%. Classically, it occurred in 74.4% in young primigeste, in 73.9% in the</span><span style="font-family:;" "=""> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">3</span><sup><span style="font-family:Verdana;">rd</span></sup><span style="font-family:Verdana;"> trimester of pregnancy and 26.1% of cases during postpartum. We recorded maternal complications such as retro-placental hematoma, acute kidney failure and delivery hemorrhage. The case fatality rate was 2.3% or 4 cases of maternal death. At the fetal level, there was 29.5% prematurity, 31.8% neonatal suffering, 11.4% hypotrophy, 11.9% </span><i><span style="font-family:Verdana;">in</span></i></span><i><span style="font-family:;" "=""> </span></i><i><span style="font-family:Verdana;">utero</span></i><span style="font-family:Verdana;"> fetal death and 7.4% early neonatal death.</span><span style="font-family:;" "=""> </span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> The maternal-fetal prognosis remains reserved despite the progress made in the management of eclampsia in our services.</span>